A public body that develops and provides guidance to UK healthcare professionals and others, to ensure that the care they provide is of the best possible quality and offers the best value for money.
People who have had a stroke should have a genetic test to ensure they get the most appropriate treatment, according to new draft guidance by NICE...
As PET launches its Power of Three campaign, find out about the research we commissioned looking at GP and NHS commissioner understanding of the NICE Fertility Guideline...
Many NHS GPs in England do not have an accurate understanding of the NICE Fertility Guideline, local funding or eligibility for referral for specialist consultation, research commissioned by the Progress Educational Trust (PET) has shown...
The Staffordshire and Stoke-on-Trent Integrated Care Board has proposed a single policy for access to NHS-funded fertility treatment for the area, that will see access for some residents reduced...
Mid and South Essex Integrated Care Board has made access to NHS-funded IVF consistent across the area, following a review...
A test which detects if a newborn baby has a genetic variant that could make them susceptible to hearing loss if given the antibiotic gentamicin, has been given conditional approval by NICE...
The fourth session of Progress Educational Trust (PET)'s 2022 Annual Conference 'Making Fertility Treatment Fair: Equality in Access, Equality in Outcome?' was chaired by Fiona Fox – founder and chief executive of the Science Media Centre, and former chair of trustees at PET...
Ovarian tissue grafts are a fertility preservation option for pre-pubertal patients undergoing treatment that could make them infertile. Sara Matthews explains what is holding back more patients in England from being able to access this service…
Transgender patients and other patients who receive treatment that may impact their fertility, will be able to access fertility preservation funded by the NHS in Bristol, North Somerset and South Gloucestershire for the first time...
An adeno-associated virus vector-based gene therapy, Hemgenix, has been approved for adults with Haemophilia B by the US Food and Drug Administration...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
